このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

This is a 2 Year Follow up Clinical and Radiographic Analysis of a Novel All Polyethelene Glenoid Component in Standard Total Shoulder Arthroplasty.

2011年3月10日 更新者:Knoxville Orthopedic Clinic
Two hundred patients will be analyzed both clinically (via validated outcomes measures) and radiographically (via 2 sets of standard radiographs) to determine the survival and degree of bone in growth of a novel all polyethelene glenoid component used in a standard FDA approved shoulder arthroplasty system.

調査の概要

詳細な説明

Methods and Materials: The standard of care in my practice and most practices is to have arthroplasty patients return for an annual clinical and radiographic evaluation. We are asking our patients that choose to enroll in the study to simply return for routine "standard of care" follow up. The only deviation from this standard of care is the method by which we obtain the xrays. In this study we will obtain true AP (anterior/posterior) and axillary views on there return visit. These are our normal "standard of care" xrays. The only difference is that we are going to obtain these Xrays using fluoroscopic guidance. The reason we are using fluoroscopic guidance is that we want to make sure that the xrays are perfect with the beam oriented tangential to the backside of the glenoid. This will allow us to see any lucencies behind the glenoid and allow us to truly assess for any loosening. Standard Xrays attempt to have the beam oriented tangential to the glenoid but just small deviations can underestimate any potential lucent lines. This will expose the study subjects to small amounts of radiation that would be outside the "standard of care". The patients will be informed of this and the dose recorded. The fluoroscopy procedure will take about 15-20 minutes, but the total radiation exposure for the activities performed will be up to, but not more than three minutes. The total radiation will be less than 3 rem. A licensed radiology technologist (RT) employed by the hospital will perform the fluoroscopy procedures and the Xrays. Jeff Jarnagin PA or Edwin Spencer MD will be present at all times during the fluoroscopy procedure. Both Dr Spencer and Jeff Jarnagin have been involved in other similar studies and have completed "training in human research subject protection". Subjects will be provided proper shielding (lead apron) throughout the activities. The licensed radiology technologist at the hospital will have the final responsibility for providing proper shielding.

As with every clinical study, there may be some risks. Since the fluoroscope emits X-rays, subjects will be exposed to radiation. During fluoroscopy, the actual dose of radiation exposure that will be administered, is within minimal risk limits and will be much lower than those known to produce detectable health effects. For this study, the fluoroscopy machine will be on for up to, but not more than, 3 minutes total and the amount of radiation will not exceed 3 rem which includes the radiation from the standard Xrays. According to published literature, exposure risks below 5-10 rem are minimal. Health effects have not been consistently demonstrated for radiation exposure below 10 rem.

Subjects will also fill out 2 data sheets. One is for the PENN score and the other is for the ASES (Association of Shoulder and Elbow Surgeons) score which are validated clinical outcomes measures. These forms are routinely filled out at their annual clinical visits and are considered standard of care.

Data Analysis: The radiographs will be independently evaluated by 2 different board certified radiologists blinded to the clinical results and names of the patients. The films will be re-evaluated by each radiologist (they will be blinded to their initial reading) and the average of their results will be recorded. The clinical ASES and PENN scores will be recorded and differences in the preoperative and postoperative scores will be reported. Statistical analysis such as a students t test is not necessary as we are not comparing two groups however simple descriptive statistics will be used to report the change in ASES and PENN scores and most importantly the presence or absence of lucent lines and location of any lucencies. The lucent lines will be graded according to the method developed by Lazarus et al.4 The medical records and Xray data will be kept as confidential as possible under current local, state, and federal laws. The researchers will examine the medical records for information related to both of the shoulders and the study data. The medical records that identify the subject and the consent form will be reviewed by the researchers. The results of this research project may be presented at meetings or in publications. The identity of the subject will not be disclosed in any presentation or publication.

The Xrays will be stored in a secure place at the Knoxville Orthopaedic Clinic. These Xrays will be accessible by only approved personnel. They will be kept indefinitely for the possibility of future use in research or publications.

Personnel who will have access to your information include:

  • Jeff Jarnagin PA (Assistant to Dr Spencer)
  • Dr. Edwin Spencer, PI (Orthopaedic Surgeon)

Risk Analysis: The only risk involved is the extra amount of radiation required to obtained the floroscopically guided Xrays. As stated above the maximum amount of radiation is 3 rem which includes the radiation from the standard Xrays. According to published literature, exposure risks below 5-10 rem are minimal. Health effects have not been consistently demonstrated for radiation exposure below 10 rem. To protect the subjects a licensed radiology technologist (RT) employed by the hospital will perform the fluoroscopy procedures and the Xrays. Jeff Jarnagin PA or Edwin Spencer MD will be present at all times during the fluoroscopy procedure. Subjects will be provided proper shielding (lead apron) throughout the activities. The licensed radiology technologist at the hospital will have the final responsibility for providing proper shielding.

The benefits to the patient is for the researchers (and readers of any published data) to garner a better understanding of the best method to resurface the glenoid in a TSA. Many patients require bilateral operations and therefore it could directly benefit a few patients but essentially this project is designed to gather information for the greater good of all patients who require a TSA.

Subject Identification, Recruitment And Consent: Subjects will be identified by a unique identification number analogous to that used by the Knoxville Orthopaedic Clinic. Subjects will be called by either Dr Edwin E Spencer Jr MD (PI) or his assistant Jeff Jarnagin PA and asked to be involved or participate. The patients will be made aware that participation in the study is completely voluntary and that participation does not affect their future access to care by Dr Spencer. Informed consent will be reviewed over the phone and in person when they come in for Xrays by Dr Spencer or his assistant Jeff Jarnagin PA. Attached is our consent form. Once the subject has completed the xray evaluation and completed the clinical forms, they will be paid the $50 stipend. The subject will incur no cost for participation in the study. Insurance carriers will not be billed for any part of the study. The money for the patients will come from the study sponsor DePuy Inc. The xrays including the floroscopy and radiologists' readings will be paid for by the study sponsor DePuy. The surgeon, Dr Spencer, will not be paid for his time and effort and is donating his time to science and the greater good.

研究の種類

介入

入学 (予想される)

200

段階

  • フェーズ 4

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Tennessee
      • Knoxville、Tennessee、アメリカ、37922
        • Knoxville Orthopaedic Clinic

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

40年~80年 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria: all patients with standard OA who had a shoulder arthroplasty with an anchor peg glenoid -

Exclusion Criteria:Any paient who had a concomitant rotator cuff tear, infection, revision or previous arthroplasty.

-

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:非ランダム化
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Single arm shoulder arthroplasty
Shoulder arthroplasty with anchor peg glenoid

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
ASES Scores
時間枠:Every 3 months
Accepted validated clinical outcome measure
Every 3 months
PENN Score
時間枠:3 months
Accepted validated outcome measure
3 months
Radiographic integration of component
時間枠:2 weeks, 6 weeks, 3 months, 2 years
Two sets of radiographs will be obtained to look for any signs of loosening and for bony integration of the component
2 weeks, 6 weeks, 3 months, 2 years

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

便利なリンク

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2011年4月1日

一次修了 (予想される)

2012年4月1日

研究の完了 (予想される)

2012年4月1日

試験登録日

最初に提出

2011年3月10日

QC基準を満たした最初の提出物

2011年3月10日

最初の投稿 (見積もり)

2011年3月14日

学習記録の更新

投稿された最後の更新 (見積もり)

2011年3月14日

QC基準を満たした最後の更新が送信されました

2011年3月10日

最終確認日

2011年3月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • Anchor Peg Study

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

3
購読する